Alvotech (NASDAQ:ALVOW – Get Free Report) shares dropped 15.8% during mid-day trading on Thursday . The stock traded as low as $0.30 and last traded at $0.32. 1,917 shares changed hands during mid-day trading, a decline of 59% from the average session volume of 4,639 shares. The stock had previously closed at $0.3799.
Alvotech Stock Down 15.8%
The business has a fifty day simple moving average of $0.21 and a 200 day simple moving average of $0.25.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Recommended Stories
- Five stocks we like better than Alvotech
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
